Monthly Prescribing Reference3h
FDA Extends Review of Tapinarof Cream for Atopic Dermatitis
The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for tapinarof cream, 1% in the treatment of atopic dermatitis in adults and ...
Monthly Prescribing Reference3h
Supply Chain Issues More Likely to Result in Drug Shortages in the US Than in Canada
One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...
Monthly Prescribing Reference5h
Lumateperone Prevents Relapse in Patients With Schizophrenia
Lumateperone, an atypical antipsychotic, is currently approved under the brand name Caplyta for the treatment of schizophrenia in adults.
Monthly Prescribing Reference7h
Nitrofurantoin, Cranberry Products May Cut UTI Episodes in Children
Review shows lower odds of symptomatic UTI episodes in children with history of recurrent UTIs with nitrofurantoin, cranberry ...
Monthly Prescribing Reference7h
Early Exposure to Nitrogen Dioxide, PM2.5 Linked to Peanut Allergy
Early-life exposure to nitrogen dioxide, fine particulate matter linked to prevalence and persistence of peanut allergy ...
Monthly Prescribing Reference7h
In a National First, an Idaho Health Department Is Refusing to Give COVID Vaccines
Board Chairman Kelly Aberasturi told the AP that while he’s skeptical of COVID vaccines, he was supportive of but “disappointed” in the board’s decision.
Monthly Prescribing Reference7h
Donidalorsen Under Review for Hereditary Angioedema
The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary angioedema (HAE) in adults and pediatric patients aged ...